GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Dr. Lal PathLabs Ltd (BOM:539524) » Definitions » Gross-Profit-to-Asset %

Dr. Lal PathLabs (BOM:539524) Gross-Profit-to-Asset % : 110.26% (As of Mar. 2025)


View and export this data going back to 2015. Start your Free Trial

What is Dr. Lal PathLabs Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Dr. Lal PathLabs's annualized Gross Profit for the quarter that ended in Mar. 2025 was ₹29,956 Mil. Dr. Lal PathLabs's average Total Assets over the quarter that ended in Mar. 2025 was ₹27,168 Mil. Therefore, Dr. Lal PathLabs's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2025 was 110.26%.


Dr. Lal PathLabs Gross-Profit-to-Asset % Historical Data

The historical data trend for Dr. Lal PathLabs's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dr. Lal PathLabs Gross-Profit-to-Asset % Chart

Dr. Lal PathLabs Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Gross-Profit-to-Asset %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 64.54 78.97 54.34 73.33 76.55

Dr. Lal PathLabs Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 109.76 64.95 67.63 60.52 110.26

Competitive Comparison of Dr. Lal PathLabs's Gross-Profit-to-Asset %

For the Diagnostics & Research subindustry, Dr. Lal PathLabs's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dr. Lal PathLabs's Gross-Profit-to-Asset % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Dr. Lal PathLabs's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Dr. Lal PathLabs's Gross-Profit-to-Asset % falls into.


;
;

Dr. Lal PathLabs Gross-Profit-to-Asset % Calculation

Dr. Lal PathLabs's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Mar. 2025 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Mar. 2025 )/( (Total Assets (A: Mar. 2024 )+Total Assets (A: Mar. 2025 ))/ count )
=19799/( (24559.63+27168)/ 2 )
=19799/25863.815
=76.55 %

Dr. Lal PathLabs's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2025 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Mar. 2025 )/( (Total Assets (Q: Dec. 2024 )+Total Assets (Q: Mar. 2025 ))/ count )
=29956/( (0+27168)/ 1 )
=29956/27168
=110.26 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Mar. 2025) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Dr. Lal PathLabs Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Dr. Lal PathLabs's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Dr. Lal PathLabs Business Description

Traded in Other Exchanges
Address
12th Floor, Tower B, SAS Tower, Sector 38, Medicity, Gurugram, HR, IND, 122 001
Dr. Lal PathLabs Ltd is a pathology lab based in India. It is involved in providing diagnostic services and other healthcare tests in the area of pathology and radiology. The company operates laboratories for carrying out pathological diagnostic services in various branches of biochemistry, hematology, histopathology, microbiology, electrophoresis, immunochemistry, immunology, virology, cytology, and other pathological and radiological investigations. Its diagnostic services assist to prevent, monitor and treat diseases and improving health conditions. The company has business operations in India and other countries, of which maximum revenue is generated within India.

Dr. Lal PathLabs Headlines

No Headlines